Within the new Biden administration policy to lower drug costs for Medicare patients, independent pharmacists are struggling to keep some prescription drugs in stock due to financial difficulties. The policy changes prescription prices for Medicare beneficiaries, adjusting them at the pharmacy counter, resulting in reduced overall costs for patients. However, this system means less money for pharmacies to acquire and stock medications. Independent pharmacists are cutting back on medications and some are even stopping acceptance of certain Medicare drug plans. President Biden’s administration has implemented laws to make drugs more affordable, but pharmacists are facing cash flow problems and hardships for some Medicare patients.
Source link